196 related articles for article (PubMed ID: 15662953)
1. Synthesis and preliminary in vitro evaluation of antimycobacterial activity of new pyrrolo[1,2-a] quinoxaline-carboxylic acid hydrazide derivatives.
Guillon J; Reynolds RC; Leger JM; Guie MA; Massip S; Dallemagne P; Jarry C
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):489-95. PubMed ID: 15662953
[TBL] [Abstract][Full Text] [Related]
2. New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents.
Torres E; Moreno E; Ancizu S; Barea C; Galiano S; Aldana I; Monge A; Pérez-Silanes S
Bioorg Med Chem Lett; 2011 Jun; 21(12):3699-703. PubMed ID: 21570839
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives.
Abdel-Aziz M; Abdel-Rahman HM
Eur J Med Chem; 2010 Aug; 45(8):3384-8. PubMed ID: 20488590
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives.
Mamolo MG; Falagiani V; Zampieri D; Vio L; Banfi E; Scialino G
Farmaco; 2003 Sep; 58(9):631-7. PubMed ID: 13679155
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antituberculosis activity of new hydrazide derivatives.
Kaplancikli ZA; Turan-Zitouni G; Ozdemir A; Teulade JC
Arch Pharm (Weinheim); 2008 Nov; 341(11):721-4. PubMed ID: 18720343
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
Moreno E; Ancizu S; Pérez-Silanes S; Torres E; Aldana I; Monge A
Eur J Med Chem; 2010 Oct; 45(10):4418-26. PubMed ID: 20656380
[TBL] [Abstract][Full Text] [Related]
7. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity.
Pavan FR; da S Maia PI; Leite SR; Deflon VM; Batista AA; Sato DN; Franzblau SG; Leite CQ
Eur J Med Chem; 2010 May; 45(5):1898-905. PubMed ID: 20163897
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
[TBL] [Abstract][Full Text] [Related]
9. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.
Manvar A; Bavishi A; Radadiya A; Patel J; Vora V; Dodia N; Rawal K; Shah A
Bioorg Med Chem Lett; 2011 Aug; 21(16):4728-31. PubMed ID: 21752642
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
Zarranz B; Jaso A; Aldana I; Monge A
Bioorg Med Chem; 2003 May; 11(10):2149-56. PubMed ID: 12713824
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antituberculosis activity of some N-pyridyl-N'-thiazolylhydrazine derivatives.
Turan-Zitouni G; Kaplancikli ZA; Ozdemir A
Eur J Med Chem; 2010 May; 45(5):2085-8. PubMed ID: 20149489
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial evaluation of some arylsulfanylpyrazinecarboxylic acid derivatives.
Jampilek J; Dolezal M; Buchta V
Med Chem; 2007 May; 3(3):277-80. PubMed ID: 17504199
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel nitrogenous heterocyclic-containing quinoxaline-1,4-di-N-oxides as potent activator of autophagy in M.tb-infected macrophages.
Zhang H; Lu Q; Zhang J; Qu W; Xie S; Huang L; Yuan Z; Pan Y
Eur J Med Chem; 2021 Nov; 223():113657. PubMed ID: 34217060
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2H-chromene and coumarin scaffold.
Angelova VT; Valcheva V; Vassilev NG; Buyukliev R; Momekov G; Dimitrov I; Saso L; Djukic M; Shivachev B
Bioorg Med Chem Lett; 2017 Jan; 27(2):223-227. PubMed ID: 27914798
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimycobacterial evaluation of N'-(E)-heteroaromaticpyrazine-2-carbohydrazide derivatives.
Lima CH; Henriques MG; Candéa AL; Lourenço MC; Bezerra FA; Ferreira ML; Kaiser CR; de Souza MV
Med Chem; 2011 May; 7(3):245-9. PubMed ID: 21486206
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimycobacterial activity of N'-[(E)-(monosubstituted-benzylidene)]-2-pyrazinecarbohydrazide derivatives.
Vergara FM; Lima CH; Henriques Md; Candéa AL; Lourenço MC; Ferreira Mde L; Kaiser CR; de Souza MV
Eur J Med Chem; 2009 Dec; 44(12):4954-9. PubMed ID: 19765866
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y
Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048
[TBL] [Abstract][Full Text] [Related]
19. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.
Ramalingam P; Ganapaty S; Rao ChB
Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
